Eli Lilly and Company (NYSE: LLY) announced the completion of its acquisition of AtaiBeckley Inc., a clinical-stage biopharmaceutical company developing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions